Everolimus forangiomyolipomaassociated withtuberous sclerosiscomplex or sporadiclymphangioleiomyomatosis (EXIST-2) John J. BisslerJ.C. KingswoodElżbieta Radzikowska2013 год

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
статья из журнала